Aspergillus PCR: One step closer to standardization

Journal of Clinical Microbiology

Volumn 48, Issue 4, 2010, Pages 1231-1240

  White, P Lewis ^a   Bretagne, Stéphane ^b   Klingspor, Lena ^c   Melchers, Willem J G ^d   McCulloch, Elaine ^e   Schulz, Bettina ^f   Finnstrom, Niklas ^g   Mengoli, Carlo ^h   Barnes, Rosemary A ^a   Donnelly, J Peter ^d   Loeffler, Juergen ⁱ  

^a UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

^b Henri Mondar Hospital   (France)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^e ROYAL HOSPITAL FOR SICK CHILDREN   (United Kingdom)

^f CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^g Cepheid AB   (France)

^h UNIVERSITY OF PADOVA   (Italy)

ⁱ UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BUFFER;

ARTICLE; ASPERGILLUS; BLOOD; BLOOD VOLUME; CLINICAL ASSESSMENT; CLINICAL PROTOCOL; CYTOLYSIS; DNA EXTRACTION; ELUTION; EXTRACTION; FUNGAL CELL; FUNGUS; GENE AMPLIFICATION; METHODOLOGY; NONHUMAN; PARAMETER; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUALITY CONTROL; REGRESSION ANALYSIS; STANDARDIZATION;

ANIMALS; ASPERGILLOSIS; ASPERGILLUS; CLINICAL LABORATORY TECHNIQUES; DNA, FUNGAL; FALSE NEGATIVE REACTIONS; MYCOLOGY; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY;

ASPERGILLUS;

EID: 77950511957     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.01767-09     Document Type: Article

References (33)

1. Ascioglu, S., J. H. Rex, B. de Pauw, J. E. Bennett, J. Bille, F. Crokaert, D. W. Denning, J. P. Donnelly, J. E. Edwards, Z. Erjavec, D. Fiere, O. Lortholary, J. Maertens, J. F. Meis, T. F. Patterson, J. Ritter, D. Selleslag, P. M. Shah, D. A. Stevens, T. J. Walsh, and the Invasive Fungal Infections Cooperative Group of the European Organization for Research and Treatment of Cancer, Mycoses Study Group of the National Institute of Allergy and Infectious Diseases. 2002. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin. Infect. Dis. 34:7-14.
2. Bossuyt, P. M., J. B. Reitsma, D. E. Bruns, C. A. Gatsonis, P. P. Glasziou, L. M. Irwig, J. G. Lijmer, D. Moher, D. Rennie, H. C. de Vet, and the STARD Group. 2003. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Fam. Pract. 21:4-10.
3. Caillot, D., J. F. Couaillier, A. Bernard, O. Casasnovas, D. W. Denning, L. Mannone, J. Lopez, G. Couillault, F. Piard, O. Vagner, and H. Guy. 2001. Increasing volume and changing characteristics of invasive pulmonary aspergillosis on sequential thoracic computed tomography scans in patients with neutropenia. J. Clin. Oncol. 19:253-259.
4. De Pauw, B., T. J. Walsh, J. P. Donnelly, D. A. Stevens, J. E. Edwards, T. Calandra, P. G. Pappas, J. Maertens, O. Lortholary, C. A. Kauffman, D. W. Denning, T. F. Patterson, G. Maschmeyer, J. Bille, W. E. Dismukes, R. Herbrecht, W. W. Hope, C. C. Kibbler, B. J. Kullberg, K. A. Marr, P. Muñoz, F. C. Odds, J. R. Perfect, A. Restrepo, M. Ruhnke, B. H. Segal, J. D. Sobel, T. C. Sorrell, C. Viscoli, J. R. Wingard, T. Zaoutis, J. E. Bennett, European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group, and National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. 2008. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin. Infect. Dis. 46:1813-1821.
5. Donnelly, J. P. 2006. Polymerase chain reaction for diagnosing invasive aspergillosis: getting closer but still a ways to go. Clin. Infect. Dis. 42:487-489.
6. Einsele, H., H. Hebart, G. Roller, J. Löffler, I. Rothenhofer, C. A. Muller, R. A. Bowden, J. van Burik, D. Engelhard, L. Kanz, and U. Schumacher. 1997. Detection and identification of fungal pathogens in blood by using molecular probes. J. Clin. Microbiol. 35:1353-1360.
7. Garcia, M. E., J. L. Blanco, J. Caballero, and D. Gargallo-Viola. 2002. Anticoagulants interfere with PCR used to diagnose invasive aspergillosis. J. Clin. Microbiol. 40:1567-1568.
8. Greene, R. E., H. T. Schlamm, J. W. Oestmann, P. Stark, C. Durand, O. Lortholary, J. R. Wingard, R. Herbrecht, P. Ribaud, T. F. Patterson, P. F. Troke, D. W. Denning, J. E. Bennett, B. E. de Pauw, and R. H. Rubin. 2007. Imaging findings in acute invasive pulmonary aspergillosis: clinical significance of the halo sign. Clin. Infect. Dis. 44:373-379.
9. Herrera, M. L., A. C. Vallor, J. A. Gelfond, T. F. Patterson, and B. L. Wickes. 2009. Strain-dependent variation in 18S ribosomal DNA copy numbers in Aspergillus fumigatus. J. Clin. Microbiol. 47:1325-1332.
10. Hope, W. W., T. J. Walsh, and D. W. Denning. 2005. Laboratory diagnosis of invasive aspergillosis. Lancet Infect. Dis. 5:609-622.
11. Irwig,L.,P.Bossuyt,P.Glasziou,C.Gatsonis,andJ.Lijmer.2002. Evidencebaseofclinicaldiagnosis:designingstudies- ensurethatestimatesoftestaccuracyaretransferable.BMJ321:669-671. (Pubitemid34234977)
12. Kami, M., T. Fukui, S. Ogawa, Y. Kazuyama, U. Machida, Y. Tanaka, Y. Kanda, T. Kashima, Y. Yamazaki, T. Hamaki, S. Mori, H. Akiyama, Y. Mutou, H. Sakamaki, K. Osumi, S. Kimura, and H. Hirai. 2001. Use of real-time PCR on blood samples for diagnosis of invasive aspergillosis. Clin. Infect. Dis. 33:1504-1512.
13. Klingspor, L., and S. Jalal. 2006. Molecular detection and identification of Candida and Aspergillus spp. from clinical samples using real-time PCR. Clin. Microbiol. Infect. 12:745-753.
14. Kontoyiannis, D. P., and K. A. Marr. 2009. Therapy of invasive aspergillosis: current consensus and controversies, p. 491-502. In J.-P. Latge and W. J. Steinbach (ed.), Aspergillus fumigatus and aspergillosis. ASM Press, Washington, DC.
15. Lengerova, M., K. Hrncirova, I. Kocmanova, Z. Racil, B. Weinbergerova, J. Vorlicek, and J. Mayer. 2008. Detection of Aspergillus fumigatus in bronchoalveolar lavage samples from immunocompromised patients using realtime PCR with fungal DNA preamplification, p.630. Abstr. 48th Intersci. Conf. Antimicrob. Agents Chemother. American Society for Microbiology, Washington, DC.
16. Loeffler, J., N. Schultze, H. Hebart, and H. Einsele. 2005. Detection of genomic DNA from Aspergillus species using the LightCycler technology, poster M-721. Abstr. 45th Intersci. Conf. Antimicrob. Agents Chemother. American Society for Microbiology, Washington, DC.
17. Loeffler, J., N. Henke, H. Hebart, D. Schmidt, L. Hagmeyer, U. Schumacher, and H. Einsele. 2000. Quantification of fungal DNA by using fluorescence resonance energy transfer and the LightCycler system. J. Clin. Microbiol. 38:586-590.
18. Loeffler, J., H. Hebart, R. Bialek, L. Hagmeyer, D. Schmidt, F. P. Serey, M. Hartmann, J. Eucker, and H. Einsele. 1999. Contaminations occurring in fungal PCR assays. J. Clin. Microbiol. 37:1200-1202.
19. Mennink-Kersten, M. A., J. P. Donnelly, and P. E. Verweij. 2004. Detection of circulating galactomannan for the diagnosis and management of invasive aspergillosis. Lancet Infect. Dis. 4:349-357.
20. Millon, L., R. Piarroux, E. Deconinck, C. E. Bulabois, F. Grenouillet, P. Rohrlich, J. M. Costa, and S. Bretagne. 2005. Use of real-time PCR to process the first galactomannan-positive serum sample in diagnosing invasive aspergillosis. J. Clin. Microbiol. 43:5097-5101.
21. Pfeiffer, C. D., J. P. Fine, and N. Safdar. 2006. Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis. Clin. Infect. Dis. 42: 1417-1427.
22. Rimek, D., A. P. Garg, W. H. Haas, and R. Kappe. 1999. Identification of contaminating fungal DNA sequences in zymolyase. J. Clin. Microbiol. 37: 830-831.
23. Schulz, B., K. Weber, C. Radecke, C. Scheer, and M. Ruhnke. 2009. Effect of different sample volumes on the DNA extraction of Aspergillus fumigatus from whole blood. Clin. Microbiol. Infect. 15:686-688.
24. Schwartz, S., and M. Ruhnke. 2009. Aspergillus sinusitis and cerebral aspergillosis, p. 301-318. In J.-P. Latge and W. J. Steinbach (ed.), Aspergillus fumigatus and aspergillosis. ASM Press, Washington, DC.
25. Sterne, J. A. C., M. J. Bradburn, and M. Egger. 2001. Meta-analysis in StataTM, p. 347-369. In M. Egger, G. Davey Smith, and D. G. Altman (ed.), Systematic reviews in health care: meta-analysis in context, 2nd ed. BMJ Publishing Group, London, United Kingdom.
26. Tong, K. B., C. J. Lau, K. Murtagh, A. J. Layton, and R. Seifeldin. 2009. The economic impact of aspergillosis: analysis of hospital expenditures across patient subgroups. Int. J. Infect. 13:24-36.
27. Upton, A., K. A. Kirby, P. Carpenter, M. Boeckh, and K. A. Marr. 2007. Invasive aspergillosis following hematopoietic cell transplantation: outcomes and prognostic factors associated with mortality. Clin. Infect. Dis. 44:531-540.
28. Van Burik, J. A., H. R. W. Schreckhise, T. C. White, R. A. Bowden, and D. Myerson. 1998. Comparison of six extraction techniques for isolation of DNA from filamentous fungi. Med. Mycol. 36:299-303.
29. White, P. L., and R. A. Barnes. 2009. Aspergillus PCR, p. 373-392. In J.-P. Latge and W. J. Steinbach (ed.), Aspergillus fumigatus and aspergillosis. ASM Press, Washington, DC.
30. White, P. L., R. Barton, M. Guiver, C. J. Linton, S. Wilson, M. Smith, B. L. Gomez, M. J. Carr, P. T. Kimmitt, S. Seaton, K. Rajakumar, T. Holyoake, C. C. Kibbler, E. Johnson, R. P. Hobson, B. Jones, and R. A. Barnes. 2006. A consensus on fungal polymerase chain reaction diagnosis?: a United Kingdom-Ireland evaluation of polymerase chain reaction methods for detection of systemic fungal infections. J. Mol. Diagn. 8:376-384.
31. White, P. L., C. J. Linton, M. D. Perry, E. M. Johnson, and R. A. Barnes. 2006. The evolution and evaluation of a whole blood polymerase chain reaction assay for the detection of invasive aspergillosis in hematology patients in a routine clinical setting. Clin. Infect. Dis. 42:479-486.
32. White, P. L., and R. A. Barnes. 2006. Aspergillus PCR-platforms, strengths and weaknesses. Med. Mycol. 44(Suppl. 1):191-198.
33. Williamson, E. C. M. 2001. Molecular approaches to fungal infections in immunocompromised patients. MD thesis. University of Bristol, Bristol, United Kingdom.